Creatd, Inc. (CRTD) Signs LOI to Acquire Remaining 90% of C2 Live

Creatd, Inc. (CRTD) signed a binding LOI to acquire 90% of C2 Live by Oct. 31, 2026. The deal includes ~$2.5M cash, a $500K breakup fee, and consideration split 20% common, 80% preferred shares, subject to approvals and diligence.

Original reporting
Published Oct 1, 2026, 1:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 1:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Creatd, Inc. (CRTD) Signs LOI to Acquire Remaining 90% of C2 Live — source image
Decision brief

The 30-second read

$CRTDNeutralMed
01

Why it matters

The transaction is a primary disclosure of a new M&A step, providing fresh information for traders.

02

Market read

A micro‑cap M&A announcement that may cause modest price movement in CRTD, with limited broader market impact.

03

What to watch

Potential regulatory approvals and integration challenges could delay or derail the transaction.

Relevance 5/10Novelty 6/10Timing: post‑close Oct 31

Background

Creatd previously owned a 10% stake in C2 Live; the LOI moves toward full ownership.

Company-level read

Ticker impact

$CRTDNeutralMedium confidence
Context

Creatd announced a binding LOI to acquire the remaining 90% of C2 Live for $2.5M cash and preferred stock, a new M&A transaction.

Expected impact

potential modest upside as the deal is priced at a discount, offset by dilution risk from preferred stock issuance

Evidence & confidence

First report of the deal provides a fresh catalyst; the small transaction size limits market impact, and the mix of common and non‑voting preferred shares creates mixed pressure.

Market effects

Adds to consolidation activity in the digital media/creator‑economy niche, but limited spillover to broader tech sector.

US‑focused; no notable regional effect.

Low; micro‑cap deal with limited global significance.

Counterpoint

The deal may overvalue C2 Live and the preferred share issuance could depress existing shareholders' equity.

Key entities

  • Creatd, Inc.

    US‑listed digital media platform seeking full control of C2 Live.

  • C2 Live

    Private creator‑economy platform targeted for acquisition.

Related articles

$CRTDLow

Creatd, Inc. (CRTD): Results of Operations and Financial Condition

Creatd, Inc. (CRTD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Creatd Regains SEC Reporting Status Company's Form S-1 Becomes Effective; Creatd Files First Periodic Report Since 2023 and Reports a Rebuilt Balance Sheet with Positive Working Capital NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) today announced that it

$HWCHighAI 9/10

Hancock Whitney to Acquire Trustmark in $3.2 Billion Deal

Hancock Whitney (HWC) will acquire Trustmark (TRMK) in an all-stock deal valued at $3.2 billion. The transaction is subject to regulatory approval and shareholder consent. According to Hancock Whitney, the combined entity will have over $160 billion in assets. The deal is expected to close in the second half of 2024.

$TECHHighAI 9/10

Merck KGaA raises 2026 outlook as Bio-Techne deal nears completion

Merck KGaA (MKKGY) reported Q3 2026 results and raised its full-year guidance for the third time this year, citing progress on its $11.3B acquisition of Bio-Techne. The company expects the deal to close by the end of 2026, subject to regulatory approvals. The acquisition is part of Merck's strategy to expand its life sciences business. According to the company, the deal will enhance its capabilities in research and diagnostics.

$IBPHighAI 9/10

Installed Building Flat on Buying Old Dominion

Installed Building Products (IBP) completed its acquisition of Old Dominion Group (ODG) for $698M, funded by 60% cash and 40% IBP stock. ODG generated $370M revenue and $68M Adjusted EBITDA in the last 12 months. IBP expects $6M-$8M in annual cost synergies within 24 months. The deal is valued at 9.3x LTM Adjusted EBITDA and is expected to be immediately accretive to IBP's revenue and margins. IBP shares traded at $209.54.